428
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6

, , , , , , & show all
Pages 241-248 | Received 14 Aug 2012, Accepted 17 Apr 2013, Published online: 15 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ling Xu, Wei Bian, Xiao-hua Gu & Ce Shen. (2017) Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:2, pages 245-250.
Read now

Articles from other publishers (12)

Lin Weng, Yaqiong Chen, Tao Liang, Yihua Lin, Dehao Liu, Ciyong Yu, Yudi Hu, Wei Lui, Yongliang Liu, Xiangfang Chen, Qiyuan Li, Shengxiang Ge, Dana P. Ascherman & Juan Chen. (2022) Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome. European Journal of Medical Research 27:1.
Crossref
Nadereh Naderi & Mahsa Rahimzadeh. (2022) Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology 566, pages 106-113.
Crossref
Ramin Rezaee & Hossein Hosseinzadeh. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 803 811 .
Thomas Planté-Bordeneuve, Charles Pilette & Antoine Froidure. (2021) The Epithelial-Immune Crosstalk in Pulmonary Fibrosis. Frontiers in Immunology 12.
Crossref
Beatriz Ballester, Javier Milara & Julio Cortijo. (2021) The role of mucin 1 in respiratory diseases. European Respiratory Review 30:159, pages 200149.
Crossref
Irina G. Luzina, Erik P. Lillehoj, Virginia Lockatell, Sang W. Hyun, Katerina N. Lugkey, Akihiro Imamura, Hideharu Ishida, Christopher W. Cairo, Sergei P. Atamas & Simeon E. Goldblum. (2021) Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis. Journal of Pharmacology and Experimental Therapeutics 376:1, pages 136-146.
Crossref
Ángel González. (2020) The Therapy of Pulmonary Fibrosis in Paracoccidioidomycosis: What Are the New Experimental Approaches?. Journal of Fungi 6:4, pages 217.
Crossref
Javier Milara, Beatriz Ballester, Paula Montero, Juan Escriva, Enrique Artigues, Manuel Alós, Alfonso Pastor-Clerigues, Esteban Morcillo & Julio Cortijo. (2020) MUC1 intracellular bioactivation mediates lung fibrosis. Thorax 75:2, pages 132-142.
Crossref
Jin Jin, Shinsaku Togo, Kotaro Kadoya, Miniwan Tulafu, Yukiko Namba, Moe Iwai, Junko Watanabe, Kumi Nagahama, Takahiro Okabe, Moulid Hidayat, Yuzo Kodama, Hideya Kitamura, Takashi Ogura, Norikazu Kitamura, Kazuho Ikeo, Shinichi Sasaki, Shigeru Tominaga & Kazuhisa Takahashi. (2019) Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1. Respiratory Research 20:1.
Crossref
Ballester, Milara & Cortijo. (2019) Mucins as a New Frontier in Pulmonary Fibrosis. Journal of Clinical Medicine 8:9, pages 1447.
Crossref
Beatriz Ballester, Javier Milara & Julio Cortijo. (2019) Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. International Journal of Molecular Sciences 20:3, pages 593.
Crossref
Zulma X. Yunt, Yael Aschner & Kevin K. Brown. 2019. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis 99 112 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.